| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-07 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.26 | 1e-06 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.26 | 3e-06 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.23 | 1e-05 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.23 | 1e-05 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.23 | 3e-05 |